I see each person as an individual functioning in their family and community. It is my role to help each person to function to their maximum potential.
Weblink Sections: National Orgs; Anxiety:Depression:Bipolar, Alcohol; Illegal Drugs: Drug Testing: Addiction Recovery:Quit Smoking: ADHD: Free Meds: Medication: Therapies:Anger Management: Books:Staying Healthy: Miscellaneous: For Providers
Check out this Time Magazine article on the latest advances and developments in addiction and on how our brains work, and the latest treatments in development. http://www.time.com/time/magazine/article/0,9171,1640436,00.html
SILVER RIBBON: Worldwide, hundreds of millions of individuals and their families are impacted by the consequences of brain disorders and disabilities. Those of us so affected must speak as one to gain maximum recognition of this.
The Silver Ribbon Coalition represents the combined interests of all those who are affected by a brain disorder or disability. To date, the Coalition is represented by advocates for anxiety disorders, autism, brain injuries, depressive disorders, mental health, Parkinson's disorder, OCD, and psychotic disorders. Ultimately, the Silver Ribbon Coalition will be represented by advocates for all types of brain disorders and disabilities.
The Silver Ribbon Campaign for the Brain promotes public awareness of the need for emotional, social, governmental, and research support of these individuals. Increasing public awareness will decrease stigma and increase support to result in improved treatment and eventual cures for those affected. Check the website under national organisations.
Study Challenges Bipolar Depression Treatment Guidelines LOS ANGELES, CA -- July 2, 2003 A study led by a UCLA Neuropsychiatric Institute researcher challenges standard treatment guidelines for bipolar depression that recommend discontinuing antidepressants within the first six months after symptoms ease.
Study participants treated under the guidelines relapsed at nearly twice the rate of those who continued taking antidepressants in conjunction with their mood stabilizer during the first year after remission of acute bipolar depression. The researchers found no increased risk of manic relapse in those who continued the medication for one year.
The findings appear in the July 2003 edition of the American Journal of Psychiatry. For more information about this finding, please visit http://www.DBSAlliance.org/headlines.html.
Dr Michael Sheehan
Dr M. Sheehan: General & Addiction Psychiatrist
Patient Login
Top
